Ashgan Elshinawy, DO
Pulmonary Disease Physician · Monroe, NJ
Ashgan Elshinawy, DO is a pulmonary disease physician with a practice address in Monroe, New Jersey, and NPI 1417907528, issued on May 11, 2006. Check the license (New Jersey MA79149, as entered in NPPES) on the New Jersey State Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Ashgan Elshinawy
- Credential
- DO
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- MA79149 NJ
Self-reported in NPPES; status is on the state search - Practice location
- 2 Research Way Ste 302, Monroe, NJ 08831
- Phone
- (609) 924-9300
- Enumerated
- May 11, 2006
- Record last updated
- Mar 27, 2023
- Fax
- (609) 430-9481
- Medicaid ID
- 0074811 NJ
- Medicare enrollment
- Enrolled (PECOS I20050825000154); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest pulmonary disease physician records → All 509 in New Jersey → Look up another NPI →
Verify Ashgan Elshinawy in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNew Jersey State Board of Medical Examiners
Search for license MA79149Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
10% fewer Medicare Part D claims than the average pulmonary disease physician in 2024
1,280 Medicare Part D claims for 241 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 40% of claims.
Most prescribed
- Albuterol Sulfate Hfa119 claims
- Temazepam102 claims
- Trelegy Ellipta100 claims
- Prednisone79 claims
- Fluticasone-Salmeterol48 claims
- Breztri Aerosphere46 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $48.26
3 payments; by number, the most common kind was food and beverage; the largest payer was Harmony Biosciences LLC. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Princeton Medical Group,p.a.Monroe Township, NJ
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Ashgan Elshinawy among 509 pulmonary disease physician records in New Jersey
Ashgan Elshinawy, DO is one of 509 pulmonary disease physician records with a practice address in New Jersey. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 11% of them.
- NPI issued2006 · 11% of these records are older, 43% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 79% of these records are
- Graduated1999 · median 1998 among the 401 with a school on file
- Record last updated2023 · 55% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a New Jersey practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
2 pulmonary disease physician records list a practice address in Monroe
They are 2 of the 152 NPPES records with a practice address in Monroe, and 509 pulmonary disease physician records in New Jersey.
All 509 in New Jersey → Every provider in Monroe → Pulmonary Disease Physician nationwide →
The 8 pulmonary disease physician records with the nearest ZIP codes
- Edward Fein, MDMonroe Township, NJ 088311629070305
- Jory Goldberg, M.D.Monroe Twp, NJ 088311407841638
- James Logothetis, M.D.Monroe Twp, NJ 088311740279124
- Nasir Malik, MDMonroe Township, NJ 088311770831984
- Anthony ScardellaMonroe Twp, NJ 088311659313609
- Barry Wolf, M.D.Monroe, NJ 088311447274402
- John Gorski, M.D.Flemington, NJ 088221760877518
- Jaime Murray, NPFlemington, NJ 088221437890480
Common questions
What is Ashgan Elshinawy, DO's NPI number?
Ashgan Elshinawy, DO's National Provider Identifier (NPI) is 1417907528, issued on May 11, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Ashgan Elshinawy, DO located?
The NPPES record lists a practice address at 2 Research Way Ste 302, Monroe, NJ, 08831. Phone: (609) 924-9300. Providers update this record themselves, so call before visiting.
How can I verify Ashgan Elshinawy, DO's license?
NPPES lists New Jersey license number MA79149, as entered by the provider. Search the New Jersey State Board of Medical Examiners at https://newjersey.mylicense.com/verification/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Ashgan Elshinawy, DO prescribe under Medicare Part D?
In 2024, Ashgan Elshinawy, DO had 1,280 Medicare Part D claims for 241 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.